Clinical Trials Logo

Clinical Trial Summary

Hypothesis: The UAS Immunotherapy protocol is efficacious and at least as efficacious as protocols described in the Allergy literature.


Clinical Trial Description

Patients will be assessed for efficacy of the immunotherapy protocol by completing Consented-IRB approved clinical, medication, quality of life survey questions comparing current status while on therapy in contrast to 12 months before the inception of therapy. ;


Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01699659
Study type Observational
Source United Allergy Services
Contact
Status Completed
Phase N/A
Start date April 2012
Completion date September 2012